Cabaletta Bio (NASDAQ: CABA ) is a company I've covered with tentative optimism, given their signals of efficacy for an approach that the medical community is gaining increasing experience with. Today, I want to take another lookI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by ...